COSYNE THERAPEUTICS LIMITED

W1F 8BH (London)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£349,999

Jan 22 - Jun 23

Commercialising the Next Generation of Synthetic Lethality: preclinical validation of lead drug-targets and discovery platform

Innovate UK award to COSYNE THERAPEUTICS LIMITED and Louwai Muhammed

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}